Al-Hujaily EM, Y Tang, D-S Yao, E Carmona, K Garson and BC Vanderhyden (2015). Divergent roles of PAX2 in the etiology and progression of ovarian cancer. Cancer Prev. Res. 8: 1163-1173.
Goldberg RL, Carter LE, Gamwell LF, Al-Hujaily EM, Collins O, Macdonald EA,
Garson K, Daneshmand M, Carmona E and Vanderhyden BC (2014). A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population. Front Oncol. 4: 53.
Hodgkinson KM, Minhas N, Perez-Iratxeta C, Vanderhyden BC
(2014). 17β-estradiol upregulates GREB1 and accelerates ovarian tumour
progression in vivo. Int.
J. Cancer. Jan 27. doi: 10.1002/ijc.28741.
Gamwell LF, M Merziotis, K Gambaro, SL
Arcand, V Snoulten, C Davis, JA Squire, DL Huntsman, PN Tonin and BC
Vanderhyden (2013). Characterization of
a small cell ovarian cancer cell line:
Genomic anomalies and responsiveness to therapeutics. Orphanet Journal of Rare Diseases 8: 33.
Gamwell LF, O
Collins and BC Vanderhyden (2012). The mouse ovarian surface epithelium
contains a population of LY6A (SCA-1) expressing progenitor cells that are
regulated by ovulation-associated factors. Biol. Reprod. 87: 80.